ArticleScientific reports2025
Advancing precision, safety, and education in D3 lymph node dissection for right hemicolectomy using mixed reality technology.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Intraoperatively available 3D vascular reconstruction navigation in robotic and laparoscopic right hemicolectomy with complete mesocolic excision: a systematic review (2000-2025).Techniques in coloproctology · 2026Pooled it
- Potential contribution of extended reality to safety in minimally invasive hepatectomy: a comparative study of laparoscopic and robotic approaches.Journal of robotic surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Right hemicolectomy (RHC) is an important treatment for colorectal cancer. The superior mesenteric artery and superior mesenteric vein are known for their significant vascular variations. This study evaluated the short-term outcomes of integrating Mixed Reality (MR) technology into RHC for the treatment of colorectal cancer. Patients who underwent RHC for clinical stage II or III colon cancer between January 2015 and August 2024 were included. Patients were divided into two groups: the MR (+) group (n = 47), in which MR was used, and the MR (-) group (n = 145), in which MR was not used. MR using SYNAPSE VINCENT, Holoeyes MD, and HoloLens2 was utilized for detailed 3D visualization of the vascular anatomy preoperatively and intraoperatively. Forty-four patients per group were matched via propensity score matching and surgical outcomes were compared. In both groups, approximately 70% of the surgeries were performed by the training surgeon. Compared with the MR (-) group, intraoperative blood loss and hospital stay were decreased, and the number of lymph nodes harvested around the middle colic artery/vein were increased without prolonging the operative time in the MR (+) group. MR in RHC offers surgical precision, safety, enhanced patient recovery, and educational value.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.